Resistin / Fizz3 Expression in Relation to Obesity and Peroxisome Proliferator - Activated Receptor-γ Action in Humans

Diabetes

Volumn 50, Issue 10, 2001, Pages 2199-2202

  Savage, David B ^a   Sewter, Ciaran P ^a   Klenk, Ellen S ^b   Segal, David G ^b   Vidal Puig, Antonio ^a   Considine, Robert V ^b   O'Rahilly, Stephen ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; HORMONE; MESSENGER RNA; RESISTIN; RETN PROTEIN, HUMAN; RETNLB PROTEIN, HUMAN; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR;

ADIPOCYTE; ADULT; ARTICLE; BLOOD; BODY MASS; CELL CULTURE; COMPUTER SYSTEM; DRUG POTENTIATION; FEMALE; GENETICS; HUMAN; MALE; METABOLISM; MONOCYTE; OBESITY; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADIPOCYTES; ADULT; BODY MASS INDEX; CELLS, CULTURED; COMPUTER SYSTEMS; FEMALE; HORMONES, ECTOPIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MONOCYTES; OBESITY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RESISTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 0035487109     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.10.2199     Document Type: Article

References (16)

1. Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W, Nelson C, Lowman HB, Wright BD, Skelton NJ, Frantz GD, Tumas DB, Peale FV Jr, Shelton DL, Hebert CC: FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. Embo J 19:4046-4055, 2000
2. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA: The hormone resistin links obesity to diabetes. Nature 409:307-312, 2001
3. Barroso I, Gurnell M, Crowley VEF, Agostini M, Schwabe JW, Soos MA, Maslen GL, Williams TDM, Lewis H, Schafer AJ, Chatterjee VKK, O'Rahilly S: Dominant negative mutations in human PPAR-γ associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402:880-883, 1999
4. Way JM, Gorgun CZ, Tong Q, Uysal KT, Brown KK, Harrington WW, Oliver WR, Willson TM, Kliewer SA, Hotamisligil GS: Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 276:25651-25653, 2001
5. Considine RV, Cooksey RC, Williams LB, Fawcett RL, Zhang P, Ambrosius WT, Whitfield RM, Jones R, Inman M, Huse J, McClain DA: Hexosamines regulate leptin production in human subcutaneous adipocytes. J Clin Endocrinol Metab 85:3551-3556, 2000
6. Adams M, Montague CT, Prins JB, Holder JC, Smith SA, Sanders L, Digby JE, Sewter CP, Lazar MA, Chatterjee VKK, O'Rahilly S: Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. J Clin Invest 100:3149-3153, 1997
7. Willson TM, Brown PJ, Sternbach DD, Henke BR: The PPARs: from orphan receptors to drug discovery (Review). J Med Chem 43:527-550, 2000
8. Kim KH, Lee K, Moon YS, Sul HS: A cysteine-rich adipose-tissue specific secretory factor inhibits adipocyte differentiation. J Biol Chem 276:11252-11256, 2001
9. Montague CT, Prins JB, Sanders L, Digby JE, O'Rahilly S: Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes 46:342-347, 1997
10. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM: Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95:2409-2415, 1995
11. Cianflone K, Maslowska M: Differentiation-induced production of ASP in human adipocytes. Eur J Clin Invest 25:817-825, 1995
12. Karlsson C, Lindell K, Ottoson M, Sjostrom L, Carlsson B, Carlsson LM: Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II. J Clin Endocrinol Metab 83:3925-3929, 1998
13. Olefsky, J.M: Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists. J Clin Invest 46:467-472, 2000
14. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87-91, 1993
15. Montague CT, Prins JB, Sanders L, Zhang J, Sewter CP. Digby J, Byrne CD, O'Rahilly S: Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes 47:1384-1391, 1998
16. Ofei F, Hurel S, Newkirk J, Sopwith M, Taylor R: Effects of an engineered human anti-TNF-α antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 45:881-885, 1996